CVS Caremark Stock Hits New 52-Week High (CVS)

NEW YORK ( TheStreet) -- CVS Caremark (NYSE: CVS) hit a new 52-week high Friday as it is currently trading at $45.41, above its previous 52-week high of $45.39 with 1.7 million shares traded as of 11:15 a.m. ET. Average volume has been 9.4 million shares over the past 30 days.

CVS Caremark has a market cap of $55.24 billion and is part of the services sector and retail industry. Shares are up 10.9% year to date as of the close of trading on Thursday.

CVS Caremark Corporation provides pharmacy health care services in the United States. The company has a P/E ratio of 17.3, above the average retail industry P/E ratio of 16.8 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates CVS Caremark as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, increase in net income and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows low profit margins. You can view the full CVS Caremark Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.